Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2011
10/19/2011CN101721405B Application of diacetylbaicalein in preparation of drugs used for curing or preventing liver diseases
10/19/2011CN101717399B Compound with pyrazine and thiazolone structure and application thereof in preparing medicament for treating diabetes mellitus
10/19/2011CN101703469B Preparation method and products of danofloxacin mesylate liposome
10/19/2011CN101697966B Application of furanodiene in preparation of medicaments for treating diseases caused by viruses
10/19/2011CN101696205B 3-(substituted xylylenimine-2-yl)-2,6-dioxopiperidine polymorph and pharmaceutical composition
10/19/2011CN101695476B Method for preparing medical nanoparticles
10/19/2011CN101693718B Ester derivative containing thienopyridine and preparation method and application thereof
10/19/2011CN101657208B A chinese medicine composition and the extract of worms thereof and their preparation
10/19/2011CN101574413B Traditional Chinese medicine preparation for curing rheumatoid arthritis and preparation method thereof
10/19/2011CN101570515B Curcumin substituted uracil derivative, preparation method and use thereof
10/19/2011CN101555291B Extraction and separation technology of ginseng polysaccharides
10/19/2011CN101541339B A percutaneous intratumoral injection composition for treating thyroma
10/19/2011CN101528215B Compositions of chk1 inhibitors and cyclodextrin
10/19/2011CN101480491B Bone collagen polypeptide composite solution for regulating intestines and preparation method thereof
10/19/2011CN101474150B Stable alprostadil injection emulsion and preparation method thereof
10/19/2011CN101439151B Medicament for treating beriberi
10/19/2011CN101439075B Medicament for increasing high density lipoprotein, preventing and treating atherosclerosis, and preparation method thereof
10/19/2011CN101421251B 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, method for the production and use thereof as medicaments
10/19/2011CN101390879B Composition containing tortoise serum and uses thereof
10/19/2011CN101384577B Novel coumarin derivative having antitumor activity
10/19/2011CN101370495B Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
10/19/2011CN101327200B Glycerol fruit sugar injection and preparation method thereof
10/19/2011CN101304995B Thiazole derivatives and use thereof
10/19/2011CN101288711B Chinese medicinal composition for treating arthritic and its preparation method
10/19/2011CN101269142B Application of Chinese medicinal composition in preparing medicament for treating right bundle branch conduction block
10/19/2011CN101268073B Heterocyclic compound, and production process and use thereof
10/19/2011CN101228126B Process for the preparation of crystalline perindopril
10/19/2011CN101223165B Ethanolamine salt of N- (3-methoxy-5-methylpyrazin-2yl) -2- (4- [1 , 3 , 4-0xadiaz0le-2-yl] phenyl) pyridine-3- sulphonamide
10/19/2011CN101204372B Cinepazide maleate injection and preparation method thereof
10/19/2011CN101189216B Desferrithiocin polyether analogues
10/19/2011CN101181601B Externally used detumescence ding-tong wine for curing orthopaedics illness
10/19/2011CN101180296B Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor Xa inhibitors
10/19/2011CN101167749B Preparing method for improving toad venom taste
10/19/2011CN101152147B Ligustrazine compound emulsion and method for preparing the same
10/19/2011CN101107247B Substituted benzoquinolizines as dpp-iv inhibitors for the treatment of diabetes
10/19/2011CN101106995B Pharmaceutical formulation for increasing solubility of 10-hydroxycamptothecin compounds in non-aqueous polar solvents
10/19/2011CN101095671B Iguratimod oral double-layer sustained-release preparation
10/19/2011CN101006072B Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
10/18/2011US8039674 Amino-substituted cyclic compound for EDG-1(endothelial differentiation gene) and/or EDG-6-mediated diseases; transplant rejection, autoimmune diseases, allergies, asthma, multiple organ failure, ischemia, reperfusion injury, lung or liver fibrosis; antitumor agents
10/18/2011US8039670 Analogs of alpha galactosyceramide and uses thereof
10/18/2011US8039668 Naphthalene-based inhibitors of anti-apoptotic proteins
10/18/2011US8039656 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them
10/18/2011US8039638 Inhibitors of HIV replication
10/18/2011US8039635 N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl) phenoxy]pentoxy} benzamidine 2 ethansulfonic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same
10/18/2011US8039632 2-aminio-pyridine derivatives and their use as potassium channel modulators
10/18/2011US8039624 Vasopressin receptor antagonist; antidepressants; anxiolytic agents; dysmemorrhea; hypotensive agents;obsessive complusive disorder; cirrhosis; nephrotic syndrome
10/18/2011US8039623 Peptidomimetics compound; viricides; interference in life cycle og hepatitis c virus
10/18/2011US8039616 Benzodiazepine derivatives for treating hepatitis C infection
10/18/2011US8039610 siRNA targeting superoxide dismutase 1 (SOD1)
10/18/2011US8039601 Crystalline forms of 1,6-Bis [3-(3-carboxymethylphenyl)-4-(2-α-D-mannopyranosyloxy)-phenyl] hexane
10/18/2011US8039514 Sulfonamide compounds and use thereof
10/18/2011US8039513 Cis-1,2-substituted stilbene derivatives and their use in preparation of drugs for treatment and/or prevention of diabetes
10/18/2011US8039512 Biologically active oils
10/18/2011US8039511 Use of isothiocyanates compounds in treating prostatic diseases and skin cancer
10/18/2011US8039510 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3′-gallate and theaflavin 3,3′-digallate and mixtures thereof
10/18/2011US8039509 Composition comprising (−)-Δ9-trans-tetrahydrocannabinol
10/18/2011US8039508 Obesity therapy; mixture of lipase inhibitor orlistat and sucrose fatty acid ester
10/18/2011US8039507 For treating inflammatory bowel disease, glaucoma or ocular hypertension, asthma; 7-[(3R*,4R*)-2-Oxo-4-((E)-3-oxo-oct-1-enyl)-pyrrolidin-3-yl]-hept-5-ynoic acid methyl ester; prostaglandin EP2 agonists
10/18/2011US8039506 Bicyclic lactam factor VIIa inhibitors useful as anticoagulants
10/18/2011US8039505 Compounds for modulating T-cells
10/18/2011US8039504 Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases
10/18/2011US8039503 Lapachone compounds and methods of use thereof
10/18/2011US8039502 Anti-infective agents against intracellular pathogens
10/18/2011US8039501 Synephrine derivatives useful as anti-inflammatory agents
10/18/2011US8039500 Fused heterocyclic compounds
10/18/2011US8039499 Ester compound and its use
10/18/2011US8039498 Imidazole compounds
10/18/2011US8039497 1,2,4-triazole derivatives as sigma receptor inhibitors
10/18/2011US8039496 Therapeutic compounds
10/18/2011US8039495 Biphenyl carboxylic acids and bioisosteres as glycogen synthase activators
10/18/2011US8039494 Compositions and methods for treating diseases of the nail
10/18/2011US8039493 Biaryl sulfonamide derivatives
10/18/2011US8039491 Modulators of ATP-binding cassette transporters
10/18/2011US8039490 Benzoyl-piperidine derivatives as dual modulators of the 5-HT2A and D3 receptors
10/18/2011US8039489 Guanidine-containing compounds useful as muscarinic receptor antagonists
10/18/2011US8039488 Methods and compositions for inhibition of angiogenesis
10/18/2011US8039487 Piperidine-amide derivatives
10/18/2011US8039486 Viricides, immunomodulators or HIV entry inhibitors; lymphadenopathy associated virus, human T-cell leukemia/lymphoma virus; AIDS
10/18/2011US8039485 Malate salts, and polymorphs of (3S,5S)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
10/18/2011US8039484 Antidiabetic bicyclic compounds
10/18/2011US8039483 Quinuclidine carbonate salts and medicinal composition thereof
10/18/2011US8039482 Composition of solifenacin or salt thereof for use in solid formulation
10/18/2011US8039481 Tetrahydrofuran derivatives for use as inhibitors of matrix metalloproteinases
10/18/2011US8039480 Spirocyclic nitriles as protease inhibitors
10/18/2011US8039479 Compounds and compositions as protein kinase inhibitors
10/18/2011US8039478 Purinone derivatives as HM74A agonists
10/18/2011US8039477 Substituted pyrazolo[3,4-d]pyrimidin-4-one compounds as phosphodiesterase inhibitors
10/18/2011US8039476 Polymorph B of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide
10/18/2011US8039475 Co-crystals and pharmaceutical compositions comprising the same
10/18/2011US8039474 2,3,4,9-tetrahydro-1H-carbazole derivatives as CRTH2 receptor antagonists
10/18/2011US8039473 Solid forms of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone
10/18/2011US8039472 Pyrazine-2-carboxamide derivatives to treat diseases mediated by blockade of the epithelial sodium channel
10/18/2011US8039471 Aza spiro alkane derivatives as inhibitors of metalloproteases
10/18/2011US8039470 Kinase inhibitor compounds
10/18/2011US8039469 Phosphatidylinositol 3 (PI3); Mammalian Target of Rapamycin, mTOR; triazine compounds substituted with either morpholino or tetrahydropyranyl rings on the triazine ring; anticancer agents, atherosclerosis, bone disorders, psoriasis, BPH, pancreatitis, kidney disease
10/18/2011US8039468 Method of inhibition of respiratory depression using positive allosteric AMPA receptor modulators
10/18/2011US8039467 Compounds for the treatment of inflammatory disorders
10/18/2011US8039466 5-hydroxymethyl-oxazolidin-2-one antibacterials
10/18/2011US8039465 Cytoskeletal active compounds, composition and use
10/18/2011US8039463 Piperazine derivatives as inhibitors of stearoyl-CoA desaturase